US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist

2.0200
+0.0100+0.50%

Close Oct 1 16:00 ET

413.99MMarket Cap-4122P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD

2024/Q2

Stock NameRevenueRatio

Business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the1.11M100.00%

Region Currency:USD

2023/FY

Stock NameRevenueRatio

United States15.45M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data